Milestone Scientific is trying to turn a long-running dental injection franchise into a reimbursed medical-device business before the cash and listing clocks expire. Chief Executive Eric Hines, hired in late summer after a stretch without consistent leadership, cut spending and is now pushing CompuFlo, the company's computerized epidural system, into clinics that can bill a technology-specific procedure code. The second-quarter print showed faster sales, but the growth mix still leans on dental distributors and two large international orders that management already flags as non-recurring. The investment debate is whether paid Medicare claims and a new federal distributor convert CompuFlo from a rounding error into a second engine before another equity raise is required.
The medical line still sits on a tiny base even after a more than threefold jump. Dental carried almost all of the $2.8 million quarter, including nearly half a million from China that is hard to treat as run-rate. Gross margin slipped as tariffs and mix hit imported components, while operating costs fell enough to narrow the loss. Cash at mid-year was only $2.1 million after a spring private placement, and the mid-year filing still carries substantial doubt about going concern. That is a thin cushion for a company that is launching direct sales in covered Medicare regions and trying to staff a federal channel.
Management restated a full-year sales band that implies only modest growth from last year and already warned that the third quarter looks slower. A University of Texas Medical Branch paper associated CompuFlo-guided access during stimulator implants with a large drop in the odds of composite complications, and Red One Medical now carries the device into Veterans Affairs and Defense channels. Those are real commercial doors. They are not yet a run-rate. The question for the next several quarters is whether paid utilization in the Novitas and First Coast regions, plus any federal evaluations, grows medical sales fast enough that the dental base can fund the company without another discounted unit sale.